Over 90% of physicians deny the scientific efficacy of nonstandard cancer treatments not covered by public medical insurance, according to a ...

Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...

After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system to cause ...

Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody ...

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't ...

Pivekimab Sunirine shows a 75% complete response rate in BPDCN patients in the CADENZA trial, offering new hope for rare ...

Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) Feb 11 (Reuters) - Researchers believe they now understand how severe cases of ...

FOR MONTHS, Tom Hayman was told by his GP his crippling stomach pains were caused by having “too many fizzy drinks” – but they turned out to be a sign of rare and incurable ...

Neutrophils are everywhere in the bloodstream and are built for speed, rushing to sites of injury or infection to contain ...